SuperCare Health looks ahead to growth, succession after Excellere deal

CITY OF INDUSTRY, Calif. – Backed by new ownership and an upcoming leadership transition, SuperCare Health is positioning itself for its next phase of growth, with plans to expand its respiratory care footprint, invest in technology and pursue strategic acquisitions.

SuperCare, which was founded in June 1974 as a small pharmacy, eventually expanding into home medical equipment (HME), was recently acquired by  Excellere Partners, a Denver-based private equity firm focused on health care, business services and industrials industries.

Today, SuperCare offers complex respiratory care solutions, including ventilators, airway oscillation, CPAP, BiPAP, oxygen concentrators and respiratory medication. It operates 27 branches across five states, serving more than 150,000 patients annually. 

“This has been my life’s work,” said John Cassar, CEO. “After more than 50 years of building SuperCare around the most complex respiratory patients, I wanted a partner who shares our values and can help carry that legacy and mission forward for the next 50 years.”

Partnering for the next chapter

Cassar says Excellere brings experience from years of working with other health care companies, along with a team and resources that will help SuperCare execute existing plans.

“Our conversations with Excellere focused on improving the patient journey and the referral experience,” he said. “That means making it easier for patients to get the care they need, easier for physicians and hospitals to work with us, and giving our employees the support to do their jobs well.”

Growing through investment and expansion

Looking ahead, Cassar sees opportunity to continue expanding SuperCare’s complex respiratory care solutions. He says the company will also continue to invest in technology and employees, as well as consider other strategic opportunities.

“We’ll also look at expansion and acquisitions where they make sense,” he said. “For me, the question is whether an opportunity strengthens our ability serve patients and maintain our standards. That’s how we’ll decide where to grow.”

Preparing the next generation of leadership

Cassar will step down as CEO in January but will remain a board member and active shareholder. He also plans to stay involved in the HME industry.

The right successor was key to succession planning. Brant Nave has been working alongside Cassar as president of SuperCare and will become CEO following his departure. Nave brings more than 20 years of respiratory and medical device experience, most recently at Aerogen.

“He brings a fresh perspective and respects what we’ve built,” said Cassar. “I’m confident that he can build on that foundation and help SuperCare reach more patients who need us.”